ArticleJournal of vascular surgery cases and innovative techniques2026
Primary aortic angiosarcoma following endovascular aneurysm repair: Case report and review of the literature.
Article in Journal of vascular surgery cases and innovative techniques, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Angiosarcoma arising in the aortic wall after endovascular aneurysm repair (EVAR) is an exceptionally rare but devastating complication. We report a case of a 76-year-old man who developed progressive systemic symptoms and persistent imaging abnormalities years after EVAR. Despite extensive workup and empirical treatment for graft infection and aortitis, diagnosis was delayed until biopsy revealed angiosarcoma. The clinical course was rapidly progressive and ultimately led to death. Atypical symptoms after EVAR should raise suspicions of malignancy. Early tissue diagnosis is essential for the timely recognition of this aggressive and frequently misdiagnosed entity, which often carries a poor prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.